Investors & Media Press Releases
Axovant to Present at First Annual Roivant Pipeline Day
A live webcast will be available in the Investors section of Axovant's website at www.axovant.com. A replay will be available for 30 days following the conference.
About Roivant Pipeline Day
Roivant Pipeline Day will be held on
Axovant is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics in the fields of neurology and psychiatry. We are developing a pipeline of clinical and nonclinical product candidates that focuses on the various aspects of debilitating neurodegenerative diseases such as Parkinson’s disease, Alzheimer's disease, Lewy body dementia, and other indications in the fields of neurology and psychiatry. Our goal is to be the leading biopharmaceutical company focused on the fields of neurology and psychiatry.
For more information, visit www.axovant.com.
Source: Axovant Sciences Ltd.